the use of statin drugs in patients with chronic kidney disease, combined with dyslipidemia
Clicks: 178
ID: 233924
2015
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
0.3
/100
1 views
1 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
For medical treatment to reduce cholesterol levels by most international cardiology and nephrology associations recommended prescriptions of statin as monotherapy or combination with other drugs. The tоpic of this article is devoted to the comparative characteristic of this group of drugs for use in patients with chronic kidney disease associated with dyslipidemia. The main part of the article is an analysis of pharmacodynamics, efficacy, safety and expediency of using rosuvastatin, a drug from the group of the last generation of statins.| Reference Key |
ivanov2015pokithe
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;D.D. Ivanov;Ya.A. Dombrovskyi |
| Journal | oncology letters |
| Year | 2015 |
| DOI | 10.22141/2307-1257.0.2.12.2015.75374 |
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.